Day: February 23, 2021

TCG BDC, Inc. Announces Fourth Quarter 2020 Financial Results and Declares First Quarter 2021 Regular Dividend of $0.32 Per Common Share and Supplemental Dividend of $0.05 per Common Share

Written by Customer Service on February 23, 2021. Posted in Earnings Releases And Operating Results.

NEW YORK, Feb. 23, 2021 (GLOBE NEWSWIRE) — TCG BDC, Inc. (together with its consolidated subsidiaries, “we,” “us,” “our,” “TCG BDC” or the “Company”) (NASDAQ: CGBD) today announced its financial results for its fourth quarter ended December 31, 2020.Linda Pace, TCG BDC’s Chief Executive Officer said, “New deal activity in the 4th quarter was robust, as M&A demand accelerated post-Labor Day. Continuing strong portfolio performance, paired with our proactive balance sheet management actions in 2020, positioned us well to participate actively in this attractive originations environment. We enter 2021 with confidence in our ability to deliver sustainable yield and continued positive credit migration as the cycle progresses.”Selected Financial HighlightsFourth Quarter 2020 Highlights(dollar amounts in thousands, except per share data)Net...

ESPERION Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Company Update

Written by Customer Service on February 23, 2021. Posted in Earnings Releases And Operating Results.

Fourth Quarter 2020 U.S. Product Revenue of $8.2 Million, Approximately 150 Percent Increase Compared to the Third QuarterOver 21,000 Patients on NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe) Tablets in the U.S.CLEAR Outcomes Study Design Highlighted in The American Heart Journal and Progresses Uninterrupted Despite PandemicConference Call and Webcast Today, February 23rdat 4:30 P.M. Eastern TimeANN ARBOR, Mich., Feb. 23, 2021 (GLOBE NEWSWIRE) — ESPERION (NASDAQ:ESPR), the lipid management company, today reported financial results for the fourth quarter and full year ended December 31, 2020 and provided a business update.“Even though 2020 was an exceptionally challenging year, we made progress in our mission of Lipid Management for Everyone. Successes include the U.S. FDA approval of NEXLETOL® and NEXLIZET®,...

Conifer Holdings Reports 2020 Fourth Quarter and Year End Financial Results

Written by Customer Service on February 23, 2021. Posted in Earnings Releases And Operating Results.

BIRMINGHAM, Mich., Feb. 23, 2021 (GLOBE NEWSWIRE) — Conifer Holdings, Inc. (Nasdaq: CNFR) (“Conifer” or the “Company”) today announced results for the fourth quarter and year ended December 31, 2020.Fourth Quarter 2020 Financial Highlights (compared to the prior year period)Gross written premium increased 13.7% to $28.9 millionCommercial Lines gross written premium increased 13.3% to $26.4 millionPersonal Lines gross written premium increased 18.5% to $2.4 millionNet income of $3.3 million, or $0.34 per share, based on 9.7 million average shares outstandingYear End 2020 Financial Highlights (compared to the prior year period)Gross written premium increased 9.3% to $111.3 millionNet income of $595,000, or $0.06 per share, based on 9.6 million average shares outstandingBook value per share of $4.59 as of December 31, 2020Management...

Goosehead Insurance, Inc. Announces Fourth Quarter and Full Year 2020 Results

Written by Customer Service on February 23, 2021. Posted in Earnings Releases And Operating Results.

– Fourth Quarter Revenues of $34.7 Million Increased 48% – – Full Year 2020 Revenues of $117.0 Million Grew 51% – – Total Written Premiums Increased 45% for the Fourth Quarter and Full Year 2020 – – Total Franchises and Corporate Sales Headcount Grew 55% and 47%, Respectively – – Full Year 2020 Net Income Growth of 81% and Adjusted EBITDA Growth of 59% –WESTLAKE, Texas, Feb. 23, 2021 (GLOBE NEWSWIRE) — Goosehead Insurance, Inc. (“Goosehead” or the “Company”) (NASDAQ: GSHD), a rapidly growing independent personal lines insurance agency, today announced results for the fourth quarter and full year ended December 31, 2020. Beginning with the fourth quarter and full year 2019, the Company began reporting results under accounting standard ASC 606. See Goosehead’s Annual...

Landos Biopharma to Participate in the SVB Leerink 10th Annual Global Healthcare Conference

Written by Customer Service on February 23, 2021. Posted in Public Companies.

BLACKSBURG, Va., Feb. 23, 2021 (GLOBE NEWSWIRE) — Landos Biopharma (Nasdaq: LABP), a clinical-stage biopharmaceutical company focused on the discovery and development of therapeutics for patients with autoimmune diseases, today announced that Dr. Josep Bassaganya-Riera, Chairman, President and Chief Executive Officer, will participate in a fireside chat at the upcoming virtual SVB Leerink 10th Annual Global Healthcare Conference on Wednesday, February 24, 2021 at 12:00 PM EST.A live webcast of the fireside chat will be accessible through the Investors/Media section of the Company’s website at www.landosbiopharma.com. Following the event, the webcast will be archived on the Landos website.About Landos BiopharmaLandos Biopharma is a clinical-stage biopharmaceutical company focused on the discovery and development of oral therapeutics...

Inventiva’s 2020 Full-Year Financial Results Presentation

Written by Customer Service on February 23, 2021. Posted in Public Companies.

Daix (France), February 23, 2021 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS) and other diseases with significant unmet medical need, today announced that its management team will host a webcast to present the Company’s full-year financial results for 2020 on Friday, March 5, 2021.Inventiva’s 2020 full-year financial results will be released on Thursday, March 4, 2021 at 4:00 pm (New York), 10:00 pm (Paris).Frédéric Cren, Chairman, CEO and cofounder of Inventiva, Pierre Broqua, Chief Scientific Officer and cofounder of Inventiva, Jean Volatier, Chief Financial Officer of Inventiva, and Michael Cooreman, Chief Medical Officer of Inventiva, will hold...

Présentation des résultats financiers 2020 d’Inventiva

Written by Customer Service on February 23, 2021. Posted in Public Companies.

Daix (France), le 23 février 2021 – Inventiva (Euronext Paris et Nasdaq : IVA), société biopharmaceutique spécialisée dans le développement clinique de petites molécules administrées par voie orale pour le traitement de la stéatohépatite non alcoolique (NASH), des mucopolysaccharidoses (MPS) et d’autres maladies avec un besoin médical non satisfait significatif annonce aujourd’hui que son équipe de direction présentera les résultats financiers 2020 de la Société le vendredi 5 mars 2021, au cours d’une présentation par webcast.Les résultats financiers 2020 d’Inventiva seront publiés le jeudi 4 mars 2021 à 16h00 (New York), 22h00 (Paris).Une conférence téléphonique, suivie d’une séance de questions/réponses, animée par Frédéric Cren, Président-directeur général et cofondateur d’Inventiva, Pierre Broqua, Directeur Scientifique et cofondateur...

HV Bancorp, Inc. Announces Common Stock Repurchase Program

Written by Customer Service on February 23, 2021. Posted in Public Companies.

DOYLESTOWN, Pa., Feb. 23, 2021 (GLOBE NEWSWIRE) — HV Bancorp, Inc. (the “Company”) (Nasdaq Capital Market: HVBC), the holding company of Huntingdon Valley Bank (the “Bank”) announced today that the Board of Directors approved a plan to repurchase, in open market and privately negotiated transactions, up to 100,000 shares of the Company’s outstanding common stock, which may be adjusted for future stock dividends, stock splits or other similar transactions. This repurchase plan will supplement the previously announced repurchase plan which is nearly complete. The Company believes the repurchase of its stock may increase the return on equity and the net income per share of the remaining outstanding shares of common stock and enhance long-term shareholder value. The purchases are funded with liquidity based on capital levels in excess...

EHang 216 AAV Completed First Trial Flights in Beijing, Capital of China

Written by Customer Service on February 23, 2021. Posted in Public Companies.

GUANGZHOU, China, Feb. 23, 2021 (GLOBE NEWSWIRE) — EHang Holdings Limited (Nasdaq: EH) (“EHang” or the “Company”), the world’s leading autonomous aerial vehicle (“AAV”) technology platform company, today announced that it recently successfully completed the first trial flights of its EH216 in Beijing. It was the first time that a passenger-grade AAV flied over the capital of China, a highly regulated airspace in China. These unmanned trial flights obtained the official approval from the airspace regulator.In February 2021, two units of EH216 completed a total of five unmanned trial flights over the frozen Yanqi Lake in Beijing at an air temperature of minus 14 degrees Celsius. EHang believes trial flights in extreme weather and diversified environments demonstrate the safety and reliability of its cutting-edge AAV technologies....

Evergold Announces Closing of Previously Upsized C$8,000,000 Bought Deal Private Placement Financing with a Lead Order from Palisades Goldcorp

Written by Customer Service on February 23, 2021. Posted in Public Companies.

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATESTORONTO, Feb. 23, 2021 (GLOBE NEWSWIRE) — Evergold Corp. (“Evergold” or the “Company”) (TSX-V: EVER) is pleased to announce that it has closed its previously announced and upsized bought deal private placement for total gross proceeds of C$8,000,000 (the “Offering”), with a lead order from Palisades Goldcorp Ltd. Under the Offering, a total of 17,500,000 units (the “HD Units”) were sold at a price of C$0.20 per HD Unit for gross proceeds of C$3,500,000 and 20,454,546 flow-through units (the “FT Units” and, together with the HD Units, the “Offered Units”) were sold at a price of C$0.22 per FT Unit for gross proceeds of C$4,500,000. Each FT Unit is comprised...

Day: February 23, 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals